Wolitzky-Taylor, K., Glasner, S., Tanner, A., Ghahremani, D. G., & London, E. D. (2022). Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept. Behaviour research and therapy, 104032.

Ekhtiari, H., Zare-Bidoky, M., Sangchooli, A., Janes, A. C., Kaufman, M. J., Oliver, J. A., ... & Zilverstand, A. (2022). A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nature Protocols, 1-31.

Ottino-González, J., Uhlmann, A., Hahn, S., Cao, Z., Cupertino, R. B., Schwab, N., ... & Garavan, H. (2022). White matter microstructure differences in individuals with dependence on cocaine, methamphetamine, and nicotine: Findings from the ENIGMA-Addiction working group. Drug and alcohol dependence230, 109185.

Hahn, S., Mackey, S., Cousijn, J., Foxe, J. J., Heinz, A., Hester, R., ... & Garavan, H. (2022). Predicting alcohol dependence from multi‐site brain structural measures. Human Brain Mapping43(1), 555-565.

Kong, X. Z., ENIGMA Laterality Working Group, Francks, C., Kong, X. Z., Mathias, S. R., Guadalupe, T., ... & Maingault, S. (2022). Reproducibility in the absence of selective reporting: An illustration from large‐scale brain asymmetry research. Human brain mapping43(1), 244-254.


van Nunen LJ, Lake MT, Ipser JC, Stein DJ, Shoptaw SJ, London ED. Executive Function and Contingency Management in Methamphetamine Use Disorder. Journal of alcoholism and drug dependence. 2021;9(5).

Petzold J, Szumlinski KK, London ED. Targeting mGlu(5) for Methamphetamine Use Disorder. Pharmacology & therapeutics. 2021;224:107831.

Petersen N, Rapkin AJ, Okita K, Kinney KR, Mizuno T, Mandelkern MA, et al. Striatal dopamine D(2)-type receptor availability and peripheral 17β-estradiol. Molecular psychiatry. 2021.

Petersen N, Kearley NW, Ghahremani DG, Pochon JB, Fry ME, Rapkin AJ, et al. Effects of oral contraceptive pills on mood and magnetic resonance imaging measures of prefrontal cortical thickness. Molecular psychiatry. 2021;26(3):917-26.

Perez Diaz M, Pochon JB, Ghahremani DG, Dean AC, Faulkner P, Petersen N, et al. Sex Differences in the Association of Cigarette Craving with Insula Structure. The international journal of neuropsychopharmacology. 2021;24(8):624-33.

Nie L, Ghahremani DG, Mandelkern MA, Dean AC, Luo W, Ren A, et al. The relationship between duration of abstinence and gray-matter brain structure in chronic methamphetamine users. The American journal of drug and alcohol abuse. 2021;47(1):65-73.

Guttman ZR, Ghahremani DG, Pochon JB, Dean AC, London ED. Age Influences Loss Aversion Through Effects on Posterior Cingulate Cortical Thickness. Frontiers in neuroscience. 2021;15:673106.

Ghahremani DG, Pochon JB, Perez Diaz M, Tyndale RF, Dean AC, London ED. Functional connectivity of the anterior insula during withdrawal from cigarette smoking. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2021.

Dean AC, Nurmi EL, Morales AM, Cho AK, Seaman LC, London ED. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users. Addiction biology. 2021;26(3):e12950.

Cao Z, Ottino-Gonzalez J, Cupertino RB, Schwab N, Hoke C, Catherine O, et al. Mapping cortical and subcortical asymmetries in substance dependence: Findings from the ENIGMA Addiction Working Group. Addiction biology. 2021;26(5):e13010.

Burnette EM, Grodin EN, Ghahremani DG, Galván A, Kohno M, Ray LA, et al. Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug and alcohol dependence. 2021;218:108391.


Yang M, Yang C, Liu T, London ED. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis. International journal of psychiatry in clinical practice. 2020;24(1):31-7.

Thorberg FA, Hasking P, Huang YL, Lyvers M, Young RM, Connor JP, et al. The Influence of Alexithymia on Alcohol Craving, Health-Related Quality of Life and Gender in Alcohol-Dependent Outpatients. Journal of psychoactive drugs. 2020;52(4):366-76.

Okafor CN, Stein DJ, Dannatt L, Ipser J, van Nunen LJ, Lake MT, et al. Contingency management treatment for methamphetamine use disorder in South Africa. Drug and alcohol review. 2020;39(3):216-22.

Moeller SJ, Kundu P, Bachi K, Maloney T, Malaker P, Parvaz MA, et al. Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry. Drug and alcohol dependence. 2020;209:107930.

London ED, Okita K, Kinney KR, Dean AC, McClintick MN, Rizor EJ, et al. No significant elevation of translocator protein binding in the brains of recently abstinent methamphetamine users. Drug and alcohol dependence. 2020;213:108104.

London ED. Human Brain Imaging Links Dopaminergic Systems to Impulsivity. Current topics in behavioral neurosciences. 2020;47:53-71.

Lim AC, Grodin EN, Green R, Venegas A, Meredith LR, Courtney KE, et al. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. The American journal of drug and alcohol abuse. 2020;46(5):565-76.

Lake MT, Shoptaw S, Ipser JC, Takada S, van Nunen LJ, Lipinska G, et al. Decision-Making by Patients With Methamphetamine Use Disorder Receiving Contingency Management Treatment: Magnitude and Frequency Effects. Frontiers in psychiatry. 2020;11:22.

Kong XZ, Francks C. Reproducibility in the absence of selective reporting: An illustration from large-scale brain asymmetry research. Human brain mapping. 2020.

Faulkner P, Dean AC, Ghahremani DG, London ED. Neural Basis of Smoking-Related Difficulties in Emotion Regulation. The international journal of neuropsychopharmacology. 2020;23(7):409-16.

Chye Y, Mackey S, Gutman BA, Ching CRK, Batalla A, Blaine S, et al. Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study. Addiction biology. 2020;25(6):e12830.

Bari AA, Sparks H, Levinson S, Wilson B, London ED, Langevin JP, et al. Amygdala Structural Connectivity Is Associated With Impulsive Choice and Difficulty Quitting Smoking. Frontiers in behavioral neuroscience. 2020;14:117.


Zorick T, Okita K, Mandelkern MA, London ED, Brody AL. Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. The international journal of neuropsychopharmacology. 2019;22(4):286-91.

Thorberg FA, Young RM, Hasking P, Lyvers M, Connor JP, London ED, et al. Alexithymia and Alcohol Dependence: The Roles of Negative Mood and Alcohol Craving. Substance use & misuse. 2019;54(14):2380-6.

Tang J, O'Neill J, Alger JR, Shen Z, Johnson MC, London ED. N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users. The international journal of neuropsychopharmacology. 2019;22(1):1-9.

Petzold J, Lee Y, Pooseh S, Oehme L, Beuthien-Baumann B, London ED, et al. Presynaptic dopamine function measured with [(18)F]fluorodopa and L-DOPA effects on impulsive choice. Scientific reports. 2019;9(1):17927.

Petzold J, Kienast A, Lee Y, Pooseh S, London ED, Goschke T, et al. Baseline impulsivity may moderate L-DOPA effects on value-based decision-making. Scientific reports. 2019;9(1):5652.

Petersen N, Ghahremani DG, Rapkin AJ, Berman SM, Wijker N, Liang L, et al. Resting-state functional connectivity in women with PMDD. Translational psychiatry. 2019;9(1):339.

Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Bø R, et al. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders. Neuroscience and biobehavioral reviews. 2019;105:288-304.

Faulkner P, Ghahremani DG, Tyndale RF, Paterson NE, Cox C, Ginder N, et al. Neural basis of smoking-induced relief of craving and negative affect: Contribution of nicotine. Addiction biology. 2019;24(5):1087-95.

Dean AC, Nurmi EL, Moeller SJ, Amir N, Rozenman M, Ghahremani DG, et al. No effect of attentional bias modification training in methamphetamine users receiving residential treatment. Psychopharmacology. 2019;236(2):709-21.

Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. The American journal of drug and alcohol abuse. 2019;45(6):563-79.


Zheutlin AB, Chekroud AM, Polimanti R, Gelernter J, Sabb FW, Bilder RM, et al. Multivariate Pattern Analysis of Genotype-Phenotype Relationships in Schizophrenia. Schizophrenia bulletin. 2018;44(5):1045-52.

Verdejo-Garcia A, Chong TT, Stout JC, Yücel M, London ED. Stages of dysfunctional decision-making in addiction. Pharmacology, biochemistry, and behavior. 2018;164:99-105.

Petersen N, London ED. Addiction and Dopamine: Sex Differences and Insights from Studies of Smoking. Current opinion in behavioral sciences. 2018;23:150-9.

Petersen N, Ghahremani DG, Rapkin AJ, Berman SM, Liang L, London ED. Brain activation during emotion regulation in women with premenstrual dysphoric disorder. Psychological medicine. 2018;48(11):1795-802.

Okita K, Morales AM, Dean AC, Johnson MC, Lu V, Farahi J, et al. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users. Molecular psychiatry. 2018;23(5):1320-7.

Nie L, Zhaom Z, Wen X, Luo W, Ju T, Ren A, et al. Factors affecting the occurrence of psychotic symptoms in chronic methamphetamine users. Journal of addictive diseases. 2018;37(3-4):202-10.

Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, et al. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2018;43(4):751-60.

Kong XZ, Mathias SR, Guadalupe T, Glahn DC, Franke B, Crivello F, et al. Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium. Proceedings of the National Academy of Sciences of the United States of America. 2018;115(22):E5154-e63.

Guttman Z, Moeller SJ, London ED. Neural underpinnings of maladaptive decision-making in addictions. Pharmacology, biochemistry, and behavior. 2018;164:84-98.

Ghahremani DG, Faulkner P, C MC, London ED. Behavioral and neural markers of cigarette-craving regulation in young-adult smokers during abstinence and after smoking. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2018;43(7):1616-22.

Faulkner P, Petersen N, Ghahremani DG, Cox CM, Tyndale RF, Hellemann GS, et al. Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers. Psychopharmacology. 2018;235(1):193-202.

Faulkner P, Ghahremani DG, Tyndale RF, Hellemann G, London ED. Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers. The international journal of neuropsychopharmacology. 2018;21(9):800-8.

Dean AC, Morales AM, Hellemann G, London ED. Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2018;43(8):1745-52.

Burggren AC, Siddarth P, Mahmood Z, London ED, Harrison TM, Merrill DA, et al. Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use. Cannabis and cannabinoid research. 2018;3(1):242-51.

Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, et al. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [(11)C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2018;43(4):925.

Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, et al. Effect of overnight smoking abstinence on a marker for microglial activation: a [(11)C]DAA1106 positron emission tomography study. Psychopharmacology. 2018;235(12):3525-34.

Ahmadi J, Jahromi MS, Ghahremani D, London ED. Single high-dose buprenorphine for opioid craving during withdrawal. Trials. 2018;19(1):675.


 Weinstein AM, Rosca P, Fattore L, London ED. Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Frontiers in psychiatry. 2017;8:156.

Roche DJO, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, et al. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology. 2017;234(13):1997-2007.

Kohno M, Morales AM, Guttman Z, London ED. A neural network that links brain function, white-matter structure and risky behavior. NeuroImage. 2017;149:15-22.

Hofmeyr A, Monterosso J, Dean AC, Morales AM, Bilder RM, Sabb FW, et al. Mixture models of delay discounting and smoking behavior. The American journal of drug and alcohol abuse. 2017;43(3):271-80.

Faulkner P, Ghahremani DG, Tyndale RF, Cox CM, Kazanjian AS, Paterson N, et al. Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2017;42(8):1610-8.

Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, et al. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [(11)C]DAA1106 Positron Emission Tomography Study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2017;42(8):1630-9.


Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend. 2016 Apr 1;161:163-70. 

Kohno M, Okita K, Morales AM, Robertson CL, Dean AC, Ghahremani DG, Sabb FW, Rawson RA, Mandelkern MA, Bilder RM, London ED. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users. Mol Psychiatry. 2016 Feb 2. [epub ahead of print]

Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, London ED. Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. Neuropsychopharmacology. 2016 Feb;41(3):695-703. Epub 2015 Jun 29.

Moeller SJ, London ED, Northoff G.Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity. Neurosci Biobehav Rev. 2016 Feb;61:35-52. Epub 2015 Dec 1. Review.


Jarcho JM, Feier NA, Labus JS, Naliboff B, Smith SR, Hong JY, Colloca L, Tillisch K, Mandelkern MA, Mayer EA, London ED.Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response. Neuroimage Clin. 2015 Nov 14;10:107-14. doi: 10.1016/j.nicl.2015.11.009.

Mackey S, Kan KJ, Chaarani B, Alia-Klein N, Batalla A, Brooks S, Cousijn J, Dagher A, de Ruiter M, Desrivieres S, Feldstein Ewing SW, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hutchison K, Li CS,London ED, Lorenzetti V, Luijten M, Martin-Santos R, Morales AM, Paulus MP, Paus T, Pearlson G, Schluter R, Momenan R, Schmaal L, Schumann G, Sinha R, Sjoerds Z, Stein DJ, Stein EA, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Walter H, Wright MJ, Yucel M, Yurgelun-Todd D, Hibar DP, Jahanshad N, Thompson PM, Glahn DC, Garavan H, Conrod P. Genetic imaging consortium for addiction medicine: From neuroimaging to genes. Prog Brain Res. 2016;224:203-23. doi: 10.1016/bs.pbr.2015.07.026. Epub 2015 Nov 4.

Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED.Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals. Int J Neuropsychopharmacol. 2015 Dec 9. pii: pyv129. doi: 10.1093/ijnp/pyv129

London ED, Kohno M, Morales AM, Ballard ME. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res. 2015 Dec 2;1628(Pt A):174-85. doi: 10.1016/j.brainres.2014.10.044. Epub 2014 Nov 4.

Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED.Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment. Neuropsychopharmacology. 2015 Nov 27. doi: 10.1038/npp.2015.331.

Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K.The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology. 2015 Sep;40(10):2347-56. doi: 10.1038/npp.2015.83. Epub 2015 Mar 24.

Dean AC, Kohno M, Morales AM, Ghahremani DG, London ED.Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.Drug Alcohol Depend. 2015 Jun 1;151:84-91. doi: 10.1016/j.drugalcdep.2015.03.004. Epub 2015 Mar 18

Morales AM, Kohno M, Robertson CL, Dean AC, Mandelkern MA, ED. London  Midbrain dopamine D2/D3 receptor availability and drug craving are associated with mesocorticolimbic gray matter volume in methamphetamine users. Mol Psychiatry. 2015 Jun;20(6):658.doi: 10.1038/mp.2015.59.

Morales AM, Kohno M, Robertson CL, Dean AC, Mandelkern MA, London ED. ..Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.  Mol Psychiatry. 2015 Jun;20(6):764-71 doi: 10.1038/mp.2015.47. Epub 2015 Apr 21

Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED. .Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence. Int J Neuropsychopharmacol. 2015 Jan 20;18(7):pyu119.doi: 10.1093/ijnp/pyu119

LA Ray, KE Courtney, DG Ghahremani, K Miotto, A Brody, ED London. (2015): Varenicline, naltrexone, and their combination for heavy-drinking smokers: Preliminary neuroimaging findings. Am. J. Drug and Alcohol Abuse.  41(1):35-44. doi: 10.3109/00952990.2014.927881.

LA Ray, S Bujarski, KE Courtney, NR Moallem, K Lunny, D Roche, A Leventhal, S Shoptaw, K Heinzerling, ED London, and K Miotto.  The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study. Neuropsychopharmacology. doi: 10.1038/npp.2015.83. [Epub ahead of print]

AM Morales, M Kohno, CL Robertson, AC Dean, M Mandelkern, and ED London (2015):  Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.Mol. Psychiatry2015 Apr 21. doi: 10.1038/mp.2015.47. [Epub ahead of print].

CL Robertson, Kenji Ishibashi, MA Mandelkern, AK Brown, DG Ghahremani, F Sabb, R Bilder, T Cannon, J Borg, ED London.  Striatal D1- and D2- type dopamine receptors are linked to motor response inhibition in human subjects. Journal of Neuroscience2015 Apr 15;35(15):5990-7. doi: 10.1523/JNEUROSCI.4850-14.2015.

AC Dean, M Kohno, AM Morales, DG Ghahremani, ED London.  Denial in methamphetamine users: associations with cognition and functional connectivity in brain. Drug and Alcohol Dependence. 2015 June 1, 151;84-91.


Courtney KE, Ghahremani DG, London ED, Ray LA (2014) The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug and alcohol dependence 141:21-26.

Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED (2014) Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA psychiatry 71:812-820.

Mooney LJ, Cooper C, London ED, Chudzynski J, Dolezal B, Dickerson D, Brecht ML, Penate J, Rawson RA (2014) Exercise for methamphetamine dependence: rationale, design, and methodology. Contemporary clinical trials 37:139-147.

Morales AM, Ghahremani D, Kohno M, Hellemann GS, London ED (2014) Cigarette exposure, dependence, and craving are related to insula thickness in young adult smokers. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 39:1816-1822.

O’Neill J, Tobias MC, Hudkins M, Oh EY, Hellemann GS, Nurmi EL, London ED (2014) Thalamic glutamate decreases with cigarette smoking. Psychopharmacology 231:2717-2724.

Ray LA, Courtney KE, Ghahremani D, Miotto K, Brody A, London E (2014a) Varenicline, naltrexone, and their combination for heavy-drinking smokers: Preliminary neuroimaging findings. Am J Drug and Alcohol Abuse (in press).

Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED (2014b) Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology 231:3843-3853.

White CN, Congdon E, Mumford JA, Karlsgodt KH, Sabb FW, Freimer NB, London ED, Cannon TD, Bilder RM, Poldrack RA (2014) Decomposing decision components in the stop-signal task: a model-based approach to individual differences in inhibitory control. Journal of cognitive neuroscience 26:1601-1614.


Congdon E, Bato AA, Schonberg T, Mumford JA, Karlsgodt KH, Sabb FW, London ED, Cannon TD, Bilder RM, Poldrack RA (2013) Differences in neural activation as a function of risk-taking task parameters. Frontiers in neuroscience 7:173.

Galvan A, Schonberg T, Mumford J, Kohno M, Poldrack RA, London ED (2013) Greater risk sensitivity of dorsolateral prefrontal cortex in young smokers than in nonsmokers. Psychopharmacology 229:345-355.

Ghahremani DG, Oh EY, Dean AC, Mouzakis K, Wilson KD, London ED (2013) Effects of the Youth Empowerment Seminar on impulsive behavior in adolescents. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 53:139-141.

Groman SM, Morales AM, Lee B, London ED, Jentsch JD (2013) Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology 229:527-538.

Ishibashi K, Robertson CL, Mandelkern MA, Morgan AT, London ED (2013) The simplified reference tissue model with 18F-fallypride positron emission tomography: choice of reference region. Molecular imaging 12.

Kohno M, Ghahremani DG, Morales AM, Robertson CL, Ishibashi K, Morgan AT, Mandelkern MA, London ED (2013) Risk-Taking Behavior: Dopamine D2/D3 Receptors, Feedback, and Frontolimbic Activity. Cerebral cortex.

Reise SP, Moore TM, Sabb FW, Brown AK, London ED (2013) The Barratt Impulsiveness Scale-11: reassessment of its structure in a community sample. Psychological assessment 25:631-642.

Swanson AN, Shoptaw S, Heinzerling KG, Wade AC, Worley M, McCracken J, Wilson SA, Asarnow J, London ED (2013) Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles. Substance use & misuse 48:1553-1562.


Brown AK, Mandelkern MA, Farahi J, Robertson C, Ghahremani DG, Sumerel B, Moallem N, London ED (2012) Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 15:989-994.

Canamar CP, London E (2012) Acute cigarette smoking reduces latencies on a Smoking Stroop test. Addictive behaviors 37:627-631.

Dean AC, Hellemann G, Sugar CA, London ED (2012) Educational attainment is not a good proxy for cognitive function in methamphetamine dependence. Drug and alcohol dependence 123:249-254.

Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N, Brown AK, Monterosso JR, Aron AR, Mandelkern MA, Poldrack RA, London ED (2012) Striatal dopamine D(2)/D(3) receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. The Journal of neuroscience : the official journal of the Society for Neuroscience 32:7316-7324.

Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA, London ED, Jentsch JD (2012) Dysregulation of D(2)-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. The Journal of neuroscience : the official journal of the Society for Neuroscience 32:5843-5852.

Hudkins M, O’Neill J, Tobias MC, Bartzokis G, London ED (2012) Cigarette smoking and white matter microstructure. Psychopharmacology 221:285-295.

Morales AM, Lee B, Hellemann G, O’Neill J, London ED (2012) Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug and alcohol dependence 125:230-238.

Payer DE, Baicy K, Lieberman MD, London ED (2012a) Overlapping neural substrates between intentional and incidental down-regulation of negative emotions. Emotion 12:229-235.

Payer DE, Nurmi EL, Wilson SA, McCracken JT, London ED (2012b) Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry. Translational psychiatry 2:e80.

Zorick T, Lee B, Mandelkern MA, Fong T, Robertson C, Ghahremani DG, Brown AK, Sumerel B, London ED (2012) Low striatal dopamine receptor availability linked to caloric intake during abstinence from chronic methamphetamine abuse. Molecular psychiatry 17:569-571.


Brody AL, Mandelkern MA, London ED, Khan A, Kozman D, Costello MR, Vellios EE, Archie MM, Bascom R, Mukhin AG (2011) Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Archives of general psychiatry 68:953-960.

Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody AL (2011) Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. Archives of general psychiatry 68:505-515.

Dean AC, Sevak RJ, Monterosso JR, Hellemann G, Sugar CA, London ED (2011a) Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. Journal of studies on alcohol and drugs 72:943-953.

Dean AC, Sugar CA, Hellemann G, London ED (2011b) Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test. Psychopharmacology 215:801-811.

Galvan A, Poldrack RA, Baker CM, McGlennen KM, London ED (2011) Neural correlates of response inhibition and cigarette smoking in late adolescence. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 36:970-978.

Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, Poldrack RA, London ED (2011) Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 36:950-959.

Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K, Rivera R, Dahlbom M, Sossi V, Vandervoort E, Jentsch JD (2011) Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. The Journal of neuroscience : the official journal of the Society for Neuroscience 31:7291-7299.

London ED, Berman SM, Chakrapani S, Delibasi T, Monterosso J, Erol HK, Paz-Filho G, Wong ML, Licinio J (2011) Short-term plasticity of gray matter associated with leptin deficiency and replacement. The Journal of clinical endocrinology and metabolism 96:E1212-1220.

Nestor LJ, Ghahremani DG, Monterosso J, London ED (2011) Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry research 194:287-295.

Payer DE, Lieberman MD, London ED (2011) Neural correlates of affect processing and aggression in methamphetamine dependence. Archives of general psychiatry 68:271-282.

Tabibnia G, Monterosso JR, Baicy K, Aron AR, Poldrack RA, Chakrapani S, Lee B, London ED (2011) Different forms of self-control share a neurocognitive substrate. The Journal of neuroscience : the official journal of the Society for Neuroscience 31:4805-4810.

Zorick T, Mandelkern MA, Lee B, Wong ML, Miotto K, Shabazian J, London ED (2011a) Elevated plasma prolactin in abstinent methamphetamine-dependent subjects. The American journal of drug and alcohol abuse 37:62-67.

Zorick T, Sugar CA, Hellemann G, Shoptaw S, London ED (2011b) Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. Drug and alcohol dependence 118:500-503.